12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. Aclarion (ACON) saw a substantial increase of 59.9%, while Clene (CLNN), Acutus Medical (AFIB), Avinger (AVGR), Blue Water Biotech (BWV), and Biora Therapeutics (BIOR) also gained. Conversely, Biophytis (BPTS), Guardant Health (GH), Syros Pharmaceuticals (SYRS), Alzamend Neuro (ALZN), Ensysce Biosciences (ENSC), and NRX Pharmaceuticals (NRXP) faced declines, with Biophytis leading the losses.
December 19, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alzamend Neuro stock declined by 6.25% to $0.9, with a market cap of $6.4 million. The company's Q2 earnings were released 2 days ago.
ALZN's recent earnings release and subsequent stock decline could continue to influence the stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Biophytis shares dropped 11.1% to $0.56, with a market cap of $5.4 million.
The significant decline in BPTS shares could continue into the short term, reflecting negative investor sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Ensysce Biosciences shares fell 6.15% to $1.07, with a market cap of $3.3 million.
ENSC's after-market decline may reflect a bearish sentiment that could persist in the short term, affecting the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Guardant Health shares fell by 7.93% to $25.69, with a market cap of $3.0 billion.
GH's after-market drop may lead to a bearish short-term outlook, potentially affecting the stock's price negatively.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
NRX Pharmaceuticals shares decreased by 5.62% to $0.37, with a market cap of $31.3 million.
The drop in NRXP shares during the after-market session could indicate a negative short-term trajectory for the stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Syros Pharmaceuticals stock decreased by 7.26% to $5.19, with a market cap of $109.4 million.
The after-market decline for SYRS could suggest a negative short-term trend, potentially leading to further price drops.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Aclarion shares soared by 59.9% to $0.47, with a market cap of $4.4 million.
The significant after-market gain for ACON indicates strong investor interest, which could lead to continued short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Acutus Medical stock climbed 6.83% to $0.21, with a market cap of $6.1 million.
AFIB's after-market increase may lead to further short-term interest from investors, potentially pushing the price up.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Avinger stock rose by 5.55% to $2.85, with a market cap of $3.6 million.
The positive movement in AVGR's after-market session could suggest a short-term bullish trend for the stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Biora Therapeutics stock increased by 5.11% to $1.23, with a market cap of $29.1 million.
The after-market rise in BIOR could signal a short-term positive trend for the stock, attracting investor interest.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Blue Water Biotech stock gained 5.26% to $0.21, with a market cap of $3.9 million.
BWV's after-market gain could indicate a positive short-term outlook, potentially leading to further price increases.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Clene stock increased by 8.1% to $0.59, with a market cap of $75.6 million.
The after-market rise for CLNN could attract more attention to the stock, potentially leading to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80